BETA

Subject "4.20.04 Pharmaceutical products and industry"

Dossiers (62)

Adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use
Supplementary protection certificate for medicinal products
Adjustment to the inflation rate of the amounts of the fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities in respect of medicinal products for human use
Principles of and guidelines for good manufacturing practice for investigational medicinal products for human use and arrangements for inspections
European Medicines Agency (EMA): location of the seat
Safety features appearing on the packaging of medicinal products for human use
Drug precursors and trade in drug precursors
Principles and guidelines of good manufacturing practice for active substances for medicinal products for human use
Situations in which post-authorisation efficacy studies may be required
Medicinal products for human and veterinary use
Avoiding trade diversion into the EU of certain key medicines. Codification
Innovative Medicines Initiative 2 Joint Undertaking (IMI2 Joint Undertaking)
Medicinal products for human use: fees payable to the European Medicines Agency for the conduct of pharmacovigilance activities
EU/Russia agreement: drug precursors
Resolution on defective silicone gel breast implants made by French company PIP
Mobilisation of the European Globalisation Adjustment Fund: redundancies in the pharmaceutical sector in Sweden
Declaration on continued and increased support for vaccinations in developing nations
Monitoring intra-EU trade in drug precursors
Monitoring EU/third country trade in drug precursors
Clinical trials on medicinal products for human use
Medicinal products for human use: transparency of measures regulating the prices and their inclusion in the scope of public health insurance systems
Pharmacovigilance: transparency and efficiency of the system. Directive
Pharmacovigilance: transparency and efficiency of the system. Regulation
Resolution on Petition 0473/2008 by Christoph Klein (German), concerning the failure of the Commission to take action regarding a competition case and the harmful impact of this on the company concerned
Duty-free treatment: specified pharmaceutical active ingredients and products
Pharmaceutical products package
Medicinal products for human use: prevention of the entry into the legal supply chain of falsified medicinal products
Medicinal products for human use: pharmacovigilance of products
Medicinal products for human use: pharmacovigilance of products
Medicinal products for human use: information on products subject to medical prescription
Medicinal products for human use: information on products subject to medical prescription
Supplementary protection certificate for medicinal products. Codification
Medicinal products for human and veterinary use: marketing authorisations
Colouring matters for medicinal products. Recast
Establishment of the Innovative Medicines Initiative Joint Undertaking
Resolution on counterfeiting of medicinal products
Declaration on pharmaceutical active substances
Community code relating to medicinal products for human use: implementing powers of the Commission
Medicinal products for paediatric use: implementing powers conferred on the Commission
Resolution on the strategy against an influenza pandemic
Medical devices and active implantable medical devices
Advanced therapy medicinal products
Fees payable to the European Medicines Agency
Pharmaceutical products: compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems
Medicinal products for paediatric use
Resolution on authorisation of generic medicines at WTO level
Chemical substances: tests, good laboratory practice (repeal. Directive 87/18/EEC). Codification
Traditional herbal medicinal products
Resolution on access to drugs for HIV/AIDS victims in the Third World
Health implications of the Directive 93/42/EEC of 14 June 1993 on medical devices
Medicinal products for human use: Community code
Authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency
Environment: substances depleting the ozone layer, metered dose inhalers and medical drug pumps
Medicinal products for human use: Community code. Codification
Pharmaceutical industry: products single market
Orphan medicinal products
Fees payable to the European Agency for the Evaluation of Medicinal Products
Homeopathic medicinal products: application of directives 92/73/EEC and 92/74/EEC. Commission report
Medicinal products for human use: implementation of good clinical practice in the conduct of clinical trials
In vitro diagnostic medical devices: security requirements
Pharmaceutical industry: outlines of an instrustrial policy for the pharmaceutical sector
European Agency for the Evaluation of Medicinal Products: fees payable